Regeneron Awarded $450 Million to Manufacture REGN-COV2

July 15, 2020

Regeneron Awarded $450 Million to Manufacture REGN-COV2

Regeneron was awarded a $450 million contract through the U.S. government-funded Operation Warp Speed to manufacture and supply REGN-COV2. The COVID-19 antibody cocktail is currently in two Phase 2/3 clinical trials. As a leader in warehouse and inventory management, Yourway can provide the full scope of all biopharmaceutical storage and distribution needs, maximizing efficiency, and decreasing risk on any candidate.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Schedule a Meeting

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat

Hello! How can I help you?